Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Toshifumi, Ito"'
Autor:
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, Yuki Tahata, Yasuharu Imai, Kazuyoshi Ohkawa, Masanori Miyazaki, Eiji Mita, Toshifumi Ito, Hideki Hagiwara, Takayuki Yakushijin, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Publikováno v:
Hepatology Research. 52:298-307
Atezolizumab plus bevacizumab was approved for hepatocellular carcinoma (HCC) patients in 2020, but treatment outcomes of atezolizumab plus bevacizumab in real-world settings remain unclear. Hyperprogressive disease (HPD), an acceleration of tumor gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8394a30f7224b8de0f4d4148e236cce
https://doi.org/10.1111/hepr.13741
https://doi.org/10.1111/hepr.13741
Autor:
Katsumi Yamamoto, Hiroshi Noro, Yu Sato, Akira Kusakabe, Nobuyuki Tatsumi, Tomoki Michida, Toshifumi Ito
Publikováno v:
Endoscopy International Open, Vol 06, Iss 03, Pp E350-E353 (2018)
Background and study aims A 70-year-old-man underwent an esophagectomy and posterior mediastinal reconstruction for esophageal cancer that was curatively resected. Although the patient was allowed to eat after surgery, he repeatedly vomited after dri
Externí odkaz:
https://doaj.org/article/57894859ea9844628960b3200a473acf
Autor:
Yukinori Yamada, Takahiro Kodama, Hideki Hagiwara, Hayato Hikita, Taizo Hijioka, Ryoko Yamada, Yuichi Yoshida, Yoshinori Doi, Tomohide Tatsumi, Hiroyuki Fukui, Naoki Hiramatsu, Kazuyoshi Ohkawa, Tetsuo Takehara, Takayuki Yakushijin, Toshifumi Ito, Masahide Oshita, Keiji Yamamoto, Shinji Tamura, Yuki Tahata, Yasuharu Imai, Ryotaro Sakamori
Publikováno v:
Alimentary Pharmacology & Therapeutics. 54:1340-1349
BACKGROUND Several factors associated with hepatocellular carcinoma (HCC) occurrence after sustained virological response (SVR) in patients with hepatitis C have been reported. However, few validation studies have been performed in the era of direct-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5dd56c61ba5bf6962cdf5ff168277b6
https://doi.org/10.1111/apt.16632
https://doi.org/10.1111/apt.16632
Autor:
Naoki Hiramatsu, Takayuki Yakushijin, Takahiro Kodama, Toshifumi Ito, Tetsuo Takehara, Kazuki Maesaka, Mitsuru Sakakibara, Yoshinori Doi, Masahide Oshita, Hideki Hagiwara, Shinji Tamura, Tomohide Tatsumi, Sadaharu Iio, Ryotaro Sakamori, Masami Inada, Ryoko Yamada, Yuki Tahata, Hayato Hikita
Publikováno v:
Hepatology Research. 51:517-527
Aim The aim of the present study was to investigate the clinical course in hepatitis C virus (HCV)-positive patients with decompensated liver cirrhosis after direct-acting antivirals (DAAs) have been used for HCV infection. Methods This multicenter s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1669fe12c756de328ba4ce6d833c9f22
https://doi.org/10.1111/hepr.13623
https://doi.org/10.1111/hepr.13623
Autor:
Kazuma Shinkai, Ryotaro Sakamori, Ryoko Yamada, Yuki Tahata, Yasutoshi Nozaki, Kengo Matsumoto, Seiichi Tawara, Kazuto Fukuda, Yuichi Yoshida, Satoshi Tanaka, Toshifumi Ito, Yoshinori Doi, Sadaharu Iio, Mitsuru Sakakibara, Fumihiko Nakanishi, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Publikováno v:
Journal of gastroenterology and hepatologyReferences. 37(6)
Balloon-occluded retrograde transvenous obliteration (BRTO) is widely performed for treating gastric varices (GVs). However, worsening of esophageal varices (EVs) can be observed after BRTO. This study aimed to investigate the impact of EV worsening
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77592e7ed3da2a06d3d5dbfd19701170
https://pubmed.ncbi.nlm.nih.gov/35430734
https://pubmed.ncbi.nlm.nih.gov/35430734
Autor:
Minoru Kato, Tomoki Michida, Akira Kusakabe, Ayako Sakai, Chihiro Hibino, Mina Kato, Yuki Tokuda, Tomoyo Kawai, Mina Hamano, Miho Chiba, Kosaku Maeda, Katsumi Yamamoto, Masafumi Naito, Toshifumi Ito
Publikováno v:
Endoscopy International Open, Vol 04, Iss 05, Pp E521-E526 (2016)
Background and study aims: Endoscopic submucosal dissection (ESD) has become widely accepted as a minimally invasive treatment for early gastric cancer (EGC), and opportunities to use ESD to treat EGC in elderly patients are increasing. The objective
Externí odkaz:
https://doaj.org/article/7bc93200be4a48a8ac6154345b283aa5
Autor:
Sadaharu Iio, Tomohide Tatsumi, Eiji Mita, Ayako Urabe, Ryoko Yamada, Kazuyoshi Ohkawa, Tetsuo Takehara, Toshifumi Ito, Takayuki Yakushijin, Hayato Hikita, Ryotaro Sakamori, Kazuki Maesaka, Masahide Oshita, Shinji Tamura, Yuki Tahata, Takahiro Kodama, Hideki Hagiwara
Publikováno v:
Hepatology Research. 50:1091-1100
Aim Preserved liver function may be an important factor affecting therapeutic efficacy in hepatocellular carcinoma patients treated with lenvatinib, but not all patients can be treated while preserving liver function. This study evaluated the therape
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f09b802cd43aed669fc54c04eb2ce36c
https://doi.org/10.1111/hepr.13537
https://doi.org/10.1111/hepr.13537
Autor:
Nobuyasu Fukutake, Makoto Ueno, Nobuyoshi Hiraoka, Kazuaki Shimada, Koichi Shiraishi, Nobuhiro Saruki, Toshifumi Ito, Minoru Yamakado, Nobukazu Ono, Akira Imaizumi, Shinya Kikuchi, Hiroshi Yamamoto, Kazuhiro Katayama
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0132223 (2015)
BackgroundThe incidence of pancreatic cancer (PC) continues to increase in the world, while most patients are diagnosed with advanced stages and survive MethodsWe conducted a cross-sectional study in multi-institutions in Japan. Fasting plasma sample
Externí odkaz:
https://doaj.org/article/6f504700f4be4393a9b9148bab6888a2
Autor:
Kazuhiro Katayama, Izumi Hamada, Atsushi Hosui, Minoru Itou, Tetsuo Takehara, Yasushi Matsuzaki, Katsunori Miyoshi, Hiroko Kodama, Keiko Hosho, Yoriyuki Takamori, Yoshiyuki Sakai, Yasuhiro Takikawa, Yoko Miyoshi, Tomomi Tsuru, Toshifumi Ito, Shinobu Ida, Kojiro Michitaka, Eishin Ogawa
Publikováno v:
Biological Trace Element Research
The essential trace element zinc maintains liver functions. Liver diseases can alter overall zinc concentrations, and hypozincemia is associated with various hepatic pathologies. Modulating systemic zinc through dietary supplementation is potentially
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f04a16d3b2bbebea4e7082653a0a5dce
http://europepmc.org/articles/PMC7150658
http://europepmc.org/articles/PMC7150658
Autor:
Akinobu Kato, Ryujin Endo, Ryuta Shigefuku, Daiki Habu, Akiko Eguchi, Kazuyuki Suzuki, Kazutomo Suzuki, Makoto Shiraki, Takaaki Ohtake, Kazuhiro Katayama, Motoh Iwasa, Koichi Shiraishi, Naohiro Kawamura, Hisataka Moriwaki, Shuhei Nishiguchi, Takumi Kawaguchi, Chizu Koreeda, Yoshio Tokumoto, Yoshiyuki Takei, Hironori Sakai, Toshifumi Ito
Publikováno v:
Hepatology Research. 49:1127-1135
Aim Hypozincemia is associated with the progression of chronic liver diseases, but it is unknown whether hypozincemia promotes human hepatocarcinogenesis. Our aim is to evaluate the serum zinc levels in liver cirrhosis (LC) patients and clarify the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2abc43f41bbed51482814f68cfab24c1
https://doi.org/10.1111/hepr.13388
https://doi.org/10.1111/hepr.13388